Abstract:The coagulation and immune system, both essential physiological systems in the human body, are intricately interconnected and play a critical role in determining the overall health of patients. These systems collaborate via various shared regulatory pathways, such as the Tissue Factor (TF) Pathway. Immunological cells that express TF and generate pro-inflammatory cytokines have the ability to affect coagulation. Conversely, coagulation factors and processes have a reciprocal effect on immunological responses by stimulating immune cells and regulating their functions. These interconnected pathways play a role in both preserving well-being and contributing to a range of pathological disorders. The close relationship between blood clotting and inflammation in the development of vascular disease has become a central focus of clinical study. This research specifically examines the crucial elements of this interaction within the contexts of cardiovascular disease and acute coronary syndrome. Tissue factor, the primary trigger of the extrinsic coagulation pathway, has a crucial function by inducing a proinflammatory reaction through the activation of coagulation factors. This, in turn, initiates coagulation and subsequent cellular signalling pathways. Protease-activated receptors establish the molecular connection between coagulation and inflammation by interacting with activated clotting factors II, X, and VII. Thrombosis, a condition characterised by the formation of blood clots, is the most dreaded consequence of cardiovascular disorders and a leading cause of death globally. Consequently, it poses a significant challenge to healthcare systems. Antithrombotic treatments efficiently target platelets and the coagulation cascade, but they come with the inherent danger of causing bleeding. Furthermore, antithrombotics are unable to fully eliminate thrombotic events, highlighting a treatment deficiency caused by a third mechanism that has not yet been sufficiently addressed, namely inflammation. Understanding these connections may aid in the development of novel approaches to mitigate the harmful mutual exacerbation of inflammation and coagulation. Gaining a comprehensive understanding of the intricate interaction among these systems is crucial for the management of diseases and the creation of efficacious remedies. Through the examination of these prevalent regulatory systems, we can discover novel therapeutic approaches that specifically target these complex illnesses. This paper provides a thorough examination of the reciprocal relationship between the coagulation and immune systems, emphasising its importance in maintaining health and understanding disease processes. This review examines the interplay between inflammation and thrombosis and its role in the development of thrombotic disorders.

Blood coagulation: a powerful bactericidal mechanism of human innate immunity

The coagulation system in host defense

Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis

Mutual regulation of CD4+ T cells and intravascular fibrin in infections

The Crossroads of the Coagulation System and the Immune System: Interactions and Connections

Neutrophil Extracellular DNA Traps in Response to Infection or Inflammation, and the Roles of Platelet Interactions

Viral coagulation: pushing the envelope

The Biology and Pathology of Innate Immunity Mechanisms

Complement-coagulation connections

Coagulation System/Physiology

Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein–kinin system

Inflammation, Sepsis, and the Coagulation System

Advance in Toxic and Pathogenic Mechanisms of Bacterial Hemolysins

Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system

New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology

Coagulation: At the heart of infective endocarditis

[Advance in sepsis-related coagulation disorders and immunity response]

Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation

Clinical and pathophysiological aspects of disseminated intravascular coagulation

TMEM173 Drives Lethal Coagulation in Sepsis

Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets